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Introduction
Flow cytometry is a qualitative and quantitative
technology that simultaneously measures and then
analyzes multiple physical characteristics of single
particles, usually cells, as they flow in a fluid  stream
through a beam of light. The properties measured include
a particle's relative size, relative granularity or internal
complexity and relative fluorescence intensity. Flow
cytometry is used for immunophenotyping of a variety of
specimens, including whole blood, bone marrow, serous
cavity fluids, cerebrospinal fluid, urine and solid
tissues.These characteristics are determined using an
optical-to-electronic coupling system that records how
the cell or particle scatters incident laser light and emits
fluorescence. Flow cytometric immunophenotyping is an
indispensable tool for the diagnosis, classification, staging,
and monitoring of hematologic neoplasms. The last 10
years have seen advances in flow cytometry
instrumentation and availability of an expanded range of
antibodies and fluorochromes that have improved our
ability to identify different normal cell populations and
recognize phenotypic aberrancies, even when present in
a small proportion of the cells analyzed (1).
Principle
Inside a flow cytometer, cells in suspension are drawn
into a stream created by a surrounding sheath of isotonic
fluid that creates laminar flow, allowing the cells to pass
individually through an interrogation point. At the
interrogation point, a beam of monochromatic light, usually
from a laser, intersects the cells. Emitted light is given
off in all directions and is collected via optics that direct
the light to a series of filters and dichromic mirrors that
isolate particular wavelength bands. The light signals are
detected by photomultiplier tubes and digitized for
computer analysis. The resulting information usually is
displayed in histogram or two-dimensional dot-plot
formats (2).
Applications in Diagnostic Pathology
DNA Content Analysis: The measurement of cellular
DNA content by flow cytometry uses fluorescent dyes,
such as propidium iodide, that intercalate into the DNA
helical structure. The fluorescent signal is directly
proportional to the amount of DNA in the nucleus and
can identify gross gains or losses in DNA. Abnormal
DNA content, also known as "DNA content aneuploidy",
can be determined in a tumor cell population. DNA
aneuploidy generally is associated with malignancy.
DNA aneuploidy correlates with a worse prognosis in
many types of cancer but is associated with improved
survival in rhabdomyosarcoma, neuroblastoma, multiple
myeloma, and childhood acute lymphoblastic leukemia
(3,4). In multiple myeloma, ALL, and myelodysplastic
syndromes, hypodiploid tumors cells portend a poor
prognosis. In contrast, hyperdiploid cells in ALL have a
better prognosis (3).
Immunophenotyping Applications in Hematology:
Many surface proteins and glycoproteins on erythrocytes,
leukocytes, and platelets have been studied in great detail.
The availability of monoclonal antibodies directed against
these surface proteins permits flow cytometric analysis
of erythrocytes, leukocytes, and platelets. Antibodies
against intracellular proteins such as myeloperoxidase and
terminal deoxynucleotidyl transferase are also
commercially available and permit analysis of an
increasing number of intracellular markers.In  Paroxysmal
nocturnal hemoglobinuria antibodies to CD55 and CD59
are specific for decay-accelerating factor and membrane-
inhibitor of reactive lysis, respectively, and can be analyzed
by flow cytometry to make a definitive diagnosis of PNH
(5,6). The flow cytometric enumeration of reticulocytes
uses fluorescent dyes that bind the residual RNA, such
as thiazole orange (7). Because the fluorescence intensity
is directly proportional to the amount of RNA and related
to the immaturity of the RBC, a reticulocyte maturity
index has been used clinically to assess bone marrow
engraftment and erythropoietic activity and to help classify
anemias (7,8). Flow cytometry has been used to
accurately identify and phenotype the recipient's red cells
(9). Flow cytometry is being used increasingly in the blood
bank to assess leukocyte contamination in leukocyte-
reduced blood products.Immunologic monitoring of HIV-
infected patients is a mainstay of the clinical flow
cytometry laboratory. The absolute CD4 count provides
a powerful laboratory measurement for predicting, staging,
and monitoring disease progression and response toJK SCIENCE
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treatment in HIV-infected individuals.Flow cytometry has
a major diagnostic role in the immunophenotyping of
leukemias and lymphomas. Flow cytometry can recognize
monoclonality  in B cell NHL more often(98%) compared
with PCR(68%).For detecting T cell clonality,PCR is
more superior(71% vs 29%).
 Flow cytometry is very effective in distinguishing
myeloid and lymphoid lineages in acute leukemias and
minimally differentiated leukemias. Flow cytometry can
also be used to identify leukemias that may be resistant
to therapy (10). Because of the wide availability and
conceptual straightforwardness of immunophenotyping,
flow cytometry is the most accessible method for Minimal
residual disease detection (11,12). In ALL, phenotype
has been shown to correlate strongly with outcome. Flow
cytometry can be used to identify neutrophils that lack
the CD11/CD18 antigen complex to establish the diagnosis
of leukocyte adhesion deficiency syndrome type I that is
otherwise difficult to make. Flow cytometry is an excellent
method for direct analysis of platelet-bound antibodies,
and it has also been shown to be of benefit in detection
of free plasma antibodies (13). Flow cytometry is a rapid
and useful method of obtaining a diagnosis of Glanzmann
thrombasthenia and  Bernard-Soulier disease. Flow
cytometry  is used for the quantification of soluble
molecules like OKT3 which is used in treating transplant
rejection. Flow cytometric enumeration of CD34+ cells
has become widely accepted as the technique of choice
to quantify HSCs for the clinical management of stem
cell transplantation.
Conclusion
Flow cytometry is a powerful technique for correlating
multiple characteristics on single cells. This qualitative
and quantitative technique has made the transition from
a research tool to standard clinical testingThe ability of
flow cytometry to identify and quantify the T cell
population subsets CD4 and CD8 lymphocytes identified
it as a most important technology in the diagnosis and
monitoring of AIDS patients. Similarly, the ability of flow
cytometry to make complex multivariate analyses of bone
marrow to identify the CD34+ cells and subsequently
sort and purify them has been a vital resource in
transplantation immunology.Flow cytometry technique
requires the passing of the cells through a fluid stream
and restricts the analysis to only cell suspension solutions.
Since flow cytometry has very sophisticated
instrumentation, only skilled and highly trained operators
can run it and get any acceptable levels of performance
from such an apparatus.  Finally the technique is very
expensive. Inspite of  a few drwawbacks, it is clear that
flow cytometry has made a significant impact in diagnostic
pathology. There are few technologies that can evaluate
so many and diverse parameters on such small
samples rapidly.
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